COLUMBANO, AMEDEO
 Distribuzione geografica
Continente #
EU - Europa 237.701
NA - Nord America 9.350
AS - Asia 1.351
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 2
Totale 248.430
Nazione #
IT - Italia 235.326
US - Stati Uniti d'America 9.291
CN - Cina 895
UA - Ucraina 877
SE - Svezia 589
DE - Germania 353
FI - Finlandia 240
SG - Singapore 237
GB - Regno Unito 186
TR - Turchia 61
CA - Canada 58
FR - Francia 51
VN - Vietnam 37
IN - India 34
KR - Corea 24
IR - Iran 22
BE - Belgio 20
RU - Federazione Russa 20
AU - Australia 18
ID - Indonesia 16
IE - Irlanda 9
JP - Giappone 9
NL - Olanda 5
AR - Argentina 4
EU - Europa 4
BG - Bulgaria 3
CH - Svizzera 3
ES - Italia 3
HK - Hong Kong 3
IL - Israele 3
MT - Malta 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
AL - Albania 1
AZ - Azerbaigian 1
BT - Bhutan 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
JO - Giordania 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 248.430
Città #
Cagliari 231.258
Uta 3.609
Fairfield 1.293
Woodbridge 854
Chandler 792
Ashburn 619
Houston 606
Wilmington 529
Boardman 520
Ann Arbor 489
Seattle 482
Nyköping 471
Jacksonville 460
Cambridge 440
Dearborn 245
Nanjing 152
Santa Clara 144
Beijing 136
Singapore 132
Helsinki 100
Boston 93
San Diego 76
Shanghai 75
Guangzhou 58
Kocaeli 58
Shenyang 57
Nanchang 56
Toronto 54
Redwood City 53
Hebei 51
Falls Church 49
San Mateo 48
Changsha 47
Mountain View 45
New York 40
Los Angeles 39
Dong Ket 36
Milan 36
Jiaxing 34
Jinan 25
Norwalk 25
Auburn Hills 24
Leawood 22
Orange 21
Tianjin 21
Augusta 20
Brussels 20
Seoul 20
Verona 20
London 18
Millbury 18
Minneapolis 16
Rome 16
Hefei 15
Ardabil 14
Zhengzhou 14
Atlanta 12
Ningbo 12
Washington 12
Monmouth Junction 11
Walnut 11
Pune 10
Wuhan 10
Dublin 9
Kilburn 9
Sassari 9
Tappahannock 9
Kunming 8
Phoenix 8
Pisa 7
Taizhou 7
Torino 7
Borås 6
Detroit 6
Frankfurt am Main 6
Indiana 6
Milwaukee 6
Munich 6
Bangalore 5
Boulder 5
Chiswick 5
Mumbai 5
Quartu Sant'elena 5
Chicago 4
Columbus 4
Hangzhou 4
San Francisco 4
Simi Valley 4
Bologna 3
Buenos Aires 3
Centro 3
Chengdu 3
Hounslow 3
Islington 3
Jinhua 3
Kobe 3
Livorno 3
Madrid 3
Melita 3
Nanning 3
Totale 244.933
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.886
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.844
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.086
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.887
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.768
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.711
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.609
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.565
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.564
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells 3.538
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.520
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.472
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 3.442
Induction of hepatocyte proliferation by retinoic acid 3.187
Clustered protocadherins methylation alterations in cancer 3.172
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand TCPOBOP 3.126
The peroxisome proliferator BR931 kills FaO cells by p53-dependent apotosis 3.063
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. 3.059
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.034
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.027
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 2.988
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3) 2.987
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.924
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.827
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.802
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes 2.685
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.676
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.613
Progenitor-derived hepatocellular carcinoma model in the rat 2.586
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.537
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.532
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.519
Estimation of a significance threshold for epigenome-wide association studies 2.456
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.416
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.407
null 2.399
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 2.380
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.374
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.300
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.284
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.277
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.273
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.216
Gadd 45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia 2.214
Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice 2.101
Proteomic characterization of early changes induced by triiodothyronine in rat liver 2.055
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.048
Triiodothyronine induces hepatocyte proliferation by protein kinase A-dependent-b-catenin activation in rodents. 2.010
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 1.991
DEXAMETHASONE INHIBITS INDUCTION OF LIVER-TUMOR NECROSIS FACTOR-ALPHA MESSENGER-RNA AND LIVER GROWTH INDUCED BY LEAD NITRATE AND ETHYLENE DIBROMIDE 1.969
Thyroid hormone receptor-β agonist induces β-catenin-dependent hepatocyte proliferation in mice: Implications in hepatic regeneration 1.877
AGING DOES NOT REDUCE THE HEPATOCYTE PROLIFERATIVE RESPONSE OF MICE TO THE PRIMARY MITOGEN TCPOBOP 1.838
METODO PER RILEVARE E/O PER LA PROGNOSI DI NEOPLASIE DEL COLON-RETTO 1.764
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model 1.758
A large set of miRNAs is dysregulated from the earliest steps of human hepatocellular carcinoma development 1.757
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis 1.721
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 1.692
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.685
Dexametasone inhibits induction of liver Tumor Necrosis Factor-a mRNA and liver growth induced by lead nitrate and ethylene dibromide 1.679
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.670
The dual roles of NRF2 in cancer 1.667
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer 1.639
Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli 1.599
Increased expression of c.fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP 1.595
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss 1.570
Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor 1.566
Differences in the steady-state levels of c-fos, c-jun and c-myc messanger RNA during mitogen-induced liver growth and compensatory regeneration 1.538
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.515
MicroRNA: New Tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? 1.507
Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation 1.484
Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of trascription factors NF-kB and AP-1 or expression of tumor necrosis factor-alfa 1.424
Met as a therapeutic target in HCC: Facts and hopes 1.380
An electron microscopic study of apoptosis induced by cycloheximide in rat liver 1.350
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.334
A common set of immediate-early response genes in liver regeneration and hyperplasia 1.317
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth 1.127
Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver 1.094
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.082
Genome-wide single nucleotide polymorphysm analysis of lung cancer risk detects the KLF6 gen 1.059
The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 989
null 951
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia 870
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 818
Stimulation of DNA synthesis after a single administration of cadmium nitrate. 816
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 812
T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues 811
HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth. 807
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate 803
Cell proliferation in rat kidney induced by 1,2-dibromoethane 800
Induction of 2 different modes of cell-death, apoptosis and necrosis, in rat-liver after a single dose of thioacetamide 790
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine 785
Occurence of cell death (Apoptosis) during the involution of liver hyperplasia 770
Liver hyperplasia and regression after lead nitrate administration 768
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA 766
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens 758
Cell deletion by apoptosis during regression of renal hyperplasia. 750
Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis 748
Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules 733
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 710
Totale 218.940
Categoria #
all - tutte 297.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 297.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039.155 0 0 0 0 15.836 10.672 5.872 1.613 935 1.063 997 2.167
2020/202157.514 1.806 2.393 2.386 14.835 11.191 6.752 5.396 3.982 1.408 2.878 2.957 1.530
2021/202213.864 1.847 1.210 687 919 1.129 1.048 748 561 1.468 1.236 1.423 1.588
2022/202319.224 1.491 2.529 2.506 1.704 1.674 1.833 994 1.502 1.175 1.324 1.568 924
2023/202419.982 1.380 925 1.896 1.415 1.808 2.537 2.702 1.442 910 1.379 1.788 1.800
2024/202523.611 7.855 8.128 3.496 3.015 1.117 0 0 0 0 0 0 0
Totale 248.777